Cancer is a leading cause of death worldwide due to its aggressive nature and complex variability. Accurate prognosis is therefore challenging but essential for guiding personalized treatment and follow-up. Previous research often relied on single data sources, missing the opportunity to combine various types of patient information for more comprehensive survival predictions. To address these challenges, we propose a two-stage fusion method named Cross-Attention and Multimodal Low-Rank Interaction Fusion Framework (CA-MLIF). In the first stage, we propose a CA mechanism for real-time feature updates and cross-modal mutual learning to capture rich semantic information. In the second stage, we design a novel multimodal low-rank interaction fusion method for survival prediction. Specifically, we present modal attention mechanism (MAM) for feature filtration, low-rank multimodal fusion (LMF) for model complexity reduction, and optimal weight concatenation (OWC) for maximizing feature integration. Extensive experiments on two public datasets TCGA-GBMLGG and TCGA-KIRC, as well as a multi-center in-house lung adenocarcinoma (LUAD) dataset validate the effectiveness of CA-MLIF, which demonstrate that our method outperforms existing approaches in survival prediction under both pathology-gene fusion and CT-pathology fusion scenarios.

To improve the overall survival rate of cancer patients, we propose an innovative approach named Multimodal Fusion Framework based on Low-rank Interaction (MF2LI), which aims to overcome the current limitations of relying solely on single-modal data prediction and the excessive complexity of fusion. By harnessing low-rank multimodal fusion (LMF) and optimal weight integration (OWI), MF2LI maximizes the integration of pathological images and genomic data. The model incorporates a parallel decomposition strategy, reducing complexity and facilitating fusion based on the contributions of each component. We validate our method using the GBMLGG and KIRC datasets from The Cancer Genome Atlas (TCGA). The C-index of the proposed model stands at $0.895 \pm 0.007$ and $0.728 \pm 0.030$ for the two datasets, respectively, outperforming existing methods. Furthermore, we generate visualizations of the risk ratios, which demonstrate a strong alignment with the actual grade classifications. Extensive experiments have shown that our model improves the prognosis prediction of tumor patients and has considerable clinical value.